# rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets

> **NCT00222625** · PHASE2 · UNKNOWN · sponsor: **University Of Perugia** · enrollment: 32 (—)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** rFVIIa + (vit K in AO patients)
- **DRUG:** FFP or aPCC+ vit K in AO treated patients

## Key facts

- **NCT ID:** NCT00222625
- **Lead sponsor:** University Of Perugia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 32 (—)
- **Last updated:** 2006-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222625, "rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00222625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*